Skip to search formSkip to main contentSkip to account menu

168 HR Clonidine 0.00833 MG/HR Transdermal System

Known as: CLONIDINE 0.2 mg in 1 d TRANSDERMAL PATCH [Clonidine], cloNIDine HCl 0.2 MG/Day Weekly Transdermal System, Clonidine 0.2 mg in 1 d TRANSDERMAL PATCH 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND ONC201 is a dopamine receptor D2 (DRD2) antagonist that penetrates the blood-brain barrier. ONC201 efficacy has been… 
2014
2014
The current investigation sought to determine whether a standard outpatient dose of dialectical behavior therapy (DBT) skills… 
Review
2013
Review
2013
High-intensity interval training (HIT) is a well-known, time-efficient training method for improving cardiorespiratory and… 
2007
2007
A33 Background: VEGFR-2 is a key regulator of angiogenesis and cancer cell growth. IMC-1121B is a recombinant human IgG1 MAb… 
2006
2006
Background: We wished to define the maximum tolerated dose (MTD), toxicity, and pharmacokinetics of the novel isoflav-3-ene, NV06… 
Highly Cited
2005
Highly Cited
2005
In view of the recent interest in weekly erythropoietic regimens and the lack of studies directly comparing the available agents… 
2004
2004
3031 Background: 17AAG is a benzoquinone antibiotic known to down regulate oncoproteins, by binding to heat shock protein 90…